US Nuclear Announces 3rd Quarter Financials and Launch of New Marketing Initiatives
US Nuclear Corp (OTC: UCLE) reported significant financial improvements in Q3 2024. The company reduced its quarterly loss by 89% to $110,971 from $760,062 in 2023. Nine-month losses decreased by 68% to $728,320 from $2,296,114 in 2023. Q3 revenues reached $610,864, up from $593,502 in 2023, while nine-month revenues improved by 9.6% to $1,741,182.
Current liabilities were reduced by 50% to $2,412,805 from year-end 2023. The company announced plans to reduce operating expenses by 20% while targeting 20% sales growth. US Nuclear is focusing on marketing nuclear monitoring product packages to nuclear providers, fire, police, paramedics, and government agencies.
US Nuclear Corp (OTC: UCLE) ha riportato importanti miglioramenti finanziari nel terzo trimestre del 2024. L'azienda ha ridotto la sua perdita trimestrale dell'89% a $110,971 rispetto ai $760,062 del 2023. Le perdite nei primi nove mesi sono diminuite del 68% a $728,320 dai $2,296,114 del 2023. I ricavi del terzo trimestre hanno raggiunto $610,864, in aumento rispetto ai $593,502 del 2023, mentre i ricavi nei primi nove mesi sono migliorati del 9,6% a $1,741,182.
Le passività correnti sono state ridotte del 50% a $2,412,805 rispetto alla fine del 2023. L'azienda ha annunciato piani per ridurre le spese operative del 20% puntando a una crescita delle vendite del 20%. US Nuclear si sta concentrando sul marketing di pacchetti di prodotti per il monitoraggio nucleare rivolti a fornitori nucleari, vigili del fuoco, polizia, paramedici e agenzie governative.
US Nuclear Corp (OTC: UCLE) informó sobre mejoras financieras significativas en el tercer trimestre de 2024. La compañía redujo su pérdida trimestral en un 89%, a $110,971 desde $760,062 en 2023. Las pérdidas en los primeros nueve meses disminuyeron en un 68%, a $728,320 desde $2,296,114 en 2023. Los ingresos del tercer trimestre alcanzaron $610,864, en comparación con $593,502 en 2023, mientras que los ingresos en los primeros nueve meses mejoraron un 9.6%, alcanzando $1,741,182.
Las obligaciones actuales se redujeron en un 50%, a $2,412,805 desde finales de 2023. La compañía anunció planes para reducir los gastos operativos en un 20% mientras busca un crecimiento en las ventas del 20%. US Nuclear se está enfocando en comercializar paquetes de productos de monitoreo nuclear a proveedores nucleares, bomberos, policías, paramédicos y agencias gubernamentales.
US Nuclear Corp (OTC: UCLE)는 2024년 3분기 동안 중요한 재무 개선을 보고했습니다. 회사는 분기 손실을 89% 줄여 2023년 $760,062에서 $110,971로 감소시켰습니다. 9개월 간 손실은 2023년 $2,296,114에서 $728,320으로 68% 감소했습니다. 3분기 수익은 2023년 $593,502에서 증가한 $610,864에 도달했으며, 9개월 수익은 9.6% 증가하여 $1,741,182에 달했습니다.
현재 부채는 2023년 연말 기준으로 50% 감소하여 $2,412,805이 되었습니다. 회사는 운영 비용을 20% 줄이고 매출 성장을 20% 목표로 하는 계획을 발표했습니다. US Nuclear는 핵 모니터링 제품 패키지를 원자력 제공업체, 소방서, 경찰, 구급대원 및 정부 기관에 마케팅하는 데 집중하고 있습니다.
US Nuclear Corp (OTC: UCLE) a rapporté des améliorations financières significatives au troisième trimestre 2024. L'entreprise a réduit sa perte trimestrielle de 89% à 110,971 $ contre 760,062 $ en 2023. Les pertes sur neuf mois ont diminué de 68% à 728,320 $ contre 2,296,114 $ en 2023. Les revenus du troisième trimestre ont atteint 610,864 $, en hausse par rapport à 593,502 $ en 2023, tandis que les revenus sur neuf mois ont augmenté de 9,6% à 1,741,182 $.
Les passifs courants ont été réduits de 50% à 2,412,805 $ par rapport à la fin de 2023. L'entreprise a annoncé des projets pour réduire les frais d'exploitation de 20% tout en visant une croissance des ventes de 20%. US Nuclear se concentre sur le marketing de paquets de produits de surveillance nucléaire à destination des fournisseurs nucléaires, des pompiers, de la police, des paramédics et des agences gouvernementales.
US Nuclear Corp (OTC: UCLE) hat im dritten Quartal 2024 bedeutende finanzielle Verbesserungen gemeldet. Das Unternehmen reduzierte seinen Quartalsverlust um 89% auf $110,971 von $760,062 im Jahr 2023. Die Verluste in den ersten neun Monaten sanken um 68% auf $728,320 von $2,296,114 im Jahr 2023. Die Einnahmen im dritten Quartal erreichten $610,864 und stiegen damit von $593,502 im Jahr 2023, während die Einnahmen in den ersten neun Monaten um 9,6% auf $1,741,182 zunahmen.
Die kurzfristigen Verbindlichkeiten wurden um 50% auf $2,412,805 seit Ende 2023 reduziert. Das Unternehmen kündigte Pläne an, die Betriebskosten um 20% zu senken und ein Verkaufswachstum von 20% anzustreben. US Nuclear konzentriert sich darauf, Pakete für die nukleare Überwachung an Anbieter von Nukleartechnologie, Feuerwehr, Polizei, Sanitäter und Regierungsbehörden zu vermarkten.
- 89% reduction in Q3 2024 losses ($110,971 vs $760,062)
- 68% decrease in nine-month losses ($728,320 vs $2,296,114)
- 9.6% increase in nine-month revenues ($1,741,182 vs $1,588,009)
- 50% reduction in current liabilities from year-end 2023
- Company still operating at a loss ($110,971 in Q3 2024)
- Modest Q3 revenue growth of only $17,362 (2.9%) year-over-year
LOS ANGELES, Dec. 04, 2024 (GLOBE NEWSWIRE) -- US Nuclear Corp. (OTC: UCLE) is pleased to announce that the 3rd quarter 2024 loss was reduced to
“These improvements in our path to profitability are just the beginning,” said Bob Goldstein, CEO of US Nuclear. “We’re working towards reducing our operating expenses
Revenues for the 3rd quarter were
Current Liabilities for the 3rd quarter 2024 were
“We are setting aggressive sales targets for our sales professionals for the year ahead,” said Mr. Goldstein, “We are going to focus first on our nuclear monitoring product line, and we’re working on assembling packages that will include all monitoring devices necessary to protect a facility. We’ll market this line not only to current and future nuclear providers, but to fire, police, paramedics and government and regulatory agencies. Our contact and current customer list is quite extensive, and we expect an exciting year ahead for the Company!”
Please use the following link to see our 3rd quarter filing: US Nuclear
For sales and product information call Bob Goldstein at (818) 472-7071, or email Mark Kohn at mark.kohn@usnuclear.com. For Investor information call Jack Lennon at Chamberlain Capital (508) 360-8407 or at jjlennon@comcast.net
FAQ
What was US Nuclear's (UCLE) Q3 2024 financial loss?
How much did US Nuclear (UCLE) reduce its current liabilities in Q3 2024?
What were US Nuclear's (UCLE) revenue figures for Q3 2024?
What is US Nuclear's (UCLE) target for operating expense reduction?
